SZM-1209

N/A

Report date: 2023/03/16 13:45:39
NME

Base Information

Drug NameSZM-1209
Drug Alias NameSZM-1209
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor-interacting serine/threonine-protein kinase 1 inhibitors
TargetsReceptor-interacting serine/threonine-protein kinase 1
Therapy Area/IndicationsAcute Lung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNingxia Medical UniversitySecond Military Medical University Of Chinese People'S Liberation ArmyUniversity Of Florida
China Registration ClassN/A

Develop Information

Active CompaniesNingxia Medical UniversityUniversity Of FloridaSecond Military Medical University Of Chinese People'S Liberation Army
Inactive CompaniesN/A
Active IndicationsAcute Lung Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A